Cargando…
Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses
PURPOSE: Hyperammonemia is an important adverse event associated with 5-fluorouracil (5FU) from 5FU metabolite accumulation. We present a case of an advanced gastric cancer patient with chronic renal failure, who was treated with 5FU/leucovorin (LV) infusion chemotherapy (2-h infusion of LV and 5FU...
Autores principales: | Ozaki, Yoshinao, Imamaki, Hirotaka, Ikeda, Aki, Oura, Mitsuaki, Nakagawa, Shunsaku, Funakoshi, Taro, Kataoka, Shigeki, Nishikawa, Yoshitaka, Horimatsu, Takahiro, Yonezawa, Atsushi, Matsubara, Takeshi, Yanagita, Motoko, Muto, Manabu, Watanabe, Norihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595983/ https://www.ncbi.nlm.nih.gov/pubmed/33011861 http://dx.doi.org/10.1007/s00280-020-04158-1 |
Ejemplares similares
-
Correction to: Successful management of hyperammonemia with hemodialysis on day 2 during 5‑fluorouracil treatment in a patient with gastric cancer: a case report with 5‑fluorouracil metabolite analyses
por: Ozaki, Yoshinao, et al.
Publicado: (2020) -
Hyperammonemia Secondary to 5-Fluorouracil
por: Scott, Ashley, et al.
Publicado: (2023) -
Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)
por: Nakamura, Michio, et al.
Publicado: (2022) -
Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines
por: Shiga, Taro, et al.
Publicado: (2020) -
Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)